Glaxosmithkline | GSK - Pre Tax Profit

Stock Price
51.74
Daily Change
-7.38 -12.48%
Monthly
-12.69%
Yearly
32.43%
Q2 Forecast
53.52

Glaxosmithkline reported GBP2.46B in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
AbbVie USD 5.57B 2.9B Mar/2026
Amgen USD 1.51B 2.41B Dec/2025
AstraZeneca USD 3.91B 1.28B Mar/2026
Aurora Cannabis CAD -1.58M 48.55M Dec/2025
Bausch Health Companies USD 56M 162M Dec/2025
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
Canopy Growth CAD -62.26M 60.84M Dec/2025
Corcept Therapeutics USD 9.91M 5.33M Dec/2025
Drreddys Laboratories INR 15.43B 1.96B Dec/2025
Eli Lilly USD 8.27B 1.03B Dec/2025
GlaxoSmithKline GBP 2.14B 919M Mar/2026
Glaxosmithkline GBP 2.46B 569M Sep/2025
J&J USD 7.82B 2.86B Mar/2026
Merck USD 3.42B 3.32B Dec/2025
Novartis USD 4.64B 445M Dec/2025
Pacira USD 571K 8.95M Dec/2025
Perrigo USD 22.4M 19.2M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Phibro Animal Health USD 38.62M 1.26M Dec/2025
Prestige Brands USD 61.81M 7.32M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
Supernus Pharmaceuticals USD -1.91M 56.04M Dec/2025
Takeda JPY 133.86B 105.69B Dec/2025
Teva Pharmaceutical Industries USD 753M 662M Mar/2026
Zoetis USD 887M 15M Sep/2025